Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Not yet recruiting"
topic_facet:"Medical Condition: Coronavirus disease 2019 (COVID-19) MedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Coronavirus+disease+2019+%28COVID-19%29+MedDRA+version%3A+20.0Level%3A+LLTClassification+code+10051905Term%3A+Coronavirus+infectionSystem+Organ+Class%3A+100000004862%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&lookfor=%22%2ACoronavirus+Infections%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Coronavirus+disease+2019+%28COVID-19%29+MedDRA+version%3A+20.0Level%3A+LLTClassification+code+10051905Term%3A+Coronavirus+infectionSystem+Organ+Class%3A+100000004862%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&lookfor=%22%2ACoronavirus+Infections%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Coronavirus+disease+2019+%28COVID-19%29+MedDRA+version%3A+20.0Level%3A+LLTClassification+code+10051905Term%3A+Coronavirus+infectionSystem+Organ+Class%3A+100000004862%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&lookfor=%22%2ACoronavirus+Infections%22&type=Subject
PubPharm (18)
1
An expanded access treatment protocol for the drug Remdesivir (RDV;GS-5734) for the treatment of SARS-CoV2 (CoV) Infection in adult subjects. COVID-19 : Expanded Access Treatment Protocol: Remdesivir (RDV;GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection- COVID-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
An expanded access treatment protocol for the drug Remdesivir (RDV;GS-5734) for the treatment of SARS-CoV2 (CoV) Infection in adult subjects. COVID-19 : Expanded Access Treatment Protocol: Remdesivir (RDV;GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection- COVID-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with severe coronavirus disease 2019 (COVID-19). : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19 - .
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
4
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with moderate coronavirus disease 2019 (COVID-19) compared to standard of care treatment. : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment - .
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
5
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with severe coronavirus disease 2019 (COVID-19). : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19 - .
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
6
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with moderate coronavirus disease 2019 (COVID-19) compared to standard of care treatment. : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment - .
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
7
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with moderate coronavirus disease 2019 (COVID-19) compared to standard of care treatment. : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
8
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with severe coronavirus disease 2019 (COVID-19). : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
9
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with moderate coronavirus disease 2019 (COVID-19) compared to standard of care treatment. : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
10
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with severe coronavirus disease 2019 (COVID-19). : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Filter aufheben
Thema: Medical Condition: Coronavirus disease 2019 (COVID-19) MedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02]
Medienart
18
Aufsätze
18
E-Artikel
18
E-Ressourcen
Zeitschriftentitel
18
WHO International Clinical Trials Registry Plat...
Thema
18
610
Medical Condition: Coronavirus disease 2019 (CO...
Recruitment Status: Not yet recruiting
18
Study Type: Interventional
16
Phase: Phase 3
2
Phase: Phase 4
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2022
16
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
18
Englisch
Haven't found what you're looking for?
Wird geladen...